Trailing-twelve-month (TTM) revenue is $3.26 Million with a year-over-year growth of +204.84%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $3,618 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-14 |
| Q4 FY2025Period ended 2025-12-31 | $8,674 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-31 |
| Q1 FY2026Period ended 2026-03-31 | $35,311 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-15 |
| Q2 FY2026Period ended 2026-06-30 | $3,214,992 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-14 |
| TTM revenue | $3,262,595 |
Current P/S: $142,030,565 market capitalization ÷ $3,262,595 TTM revenue = 43.53x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T17:44:33.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $3.21M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T17:45:25.408Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2024-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2019-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD |
|---|---|---|---|---|---|---|
| Domestic | $1M | N/A | N/A | N/A | N/A | N/A |
| Helomics Segment | $48,447 | $64,188 |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20172017-12-31 · USD | FY20192019-12-31 · USD |
|---|---|---|
| Domestic | N/A | $1M |
| Non-US | $26,662 | N/A |
$3.26M
$3.26 Million
+204.84%
vs. $1.07M a year ago (TTM)
(36.90%)
5 Year compound annual growth rate
1 Year
+204.84%
3 Year
+28.17%
5 Year
(36.90%)
10 Year
+21.87%
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $125,284 | ($1.50M) | (92.28%) |
| 2024 | $1.62M | ($3,880) | (0.24%) |
| 2023 | $1.63M | +$122,238 | +8.12% |
| 2022 | $1.51M | +$84,779 | +5.97% |
| 2021 | $1.42M | +$168,408 | +13.45% |
| 2020 |
TTM Growth
+204.84%
3-Year CAGR
+28.17%
5-Year CAGR
(36.90%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T17:45:25.408Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| $6,397 |
| N/A |
| N/A |
| International | $88,070 | N/A | N/A | N/A | N/A | N/A |
|---|
| Pittsburgh | N/A | N/A | N/A | N/A | $492,596 | $84,812 |
|---|
| Skyline | N/A | $1M | $1M | $1M | N/A | N/A |
|---|
| Soluble | N/A | $2,870 | $233,293 | $82,301 | N/A | N/A |
|---|
| zPREDICTA | N/A | N/A | $90 | $352,379 | N/A | N/A |
|---|
| $1.25M |
| ($159,293) |
| (11.28%) |
| 2019 | $1.41M | ($90) | (0.01%) |
| 2018 | $1.41M | +$756,819 | +115.57% |
| 2017 | $654,836 | +$198,341 | +43.45% |
| 2016 | $456,495 | ($197,859) | (30.24%) |
